Extrawell Pharmaceutical Holdings Limited (0858.HK)
HKD 0.05
(-1.89%)
HKD 0.05
(-1.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7.26 Million HKD | 85.14% |
| 2022 | 3.92 Million HKD | -68.94% |
| 2021 | 12.63 Million HKD | 53.79% |
| 2020 | 8.21 Million HKD | -3.14% |
| 2019 | 8.48 Million HKD | 45.6% |
| 2018 | 5.82 Million HKD | 42.05% |
| 2017 | 4.09 Million HKD | -46.1% |
| 2016 | 7.6 Million HKD | 28.41% |
| 2015 | 5.92 Million HKD | -65.26% |
| 2014 | 17.05 Million HKD | 84.82% |
| 2013 | 9.22 Million HKD | -29.85% |
| 2012 | 13.15 Million HKD | 1.31% |
| 2011 | 12.98 Million HKD | -14.78% |
| 2010 | 15.23 Million HKD | -34.12% |
| 2009 | 23.12 Million HKD | -18.27% |
| 2008 | 28.29 Million HKD | 51.78% |
| 2007 | 18.63 Million HKD | 49.67% |
| 2006 | 12.45 Million HKD | -15.67% |
| 2005 | 14.76 Million HKD | -5.89% |
| 2004 | 15.69 Million HKD | 56.38% |
| 2003 | 10.03 Million HKD | -16.41% |
| 2002 | 12 Million HKD | 2.35% |
| 2001 | 11.72 Million HKD | -7.11% |
| 2000 | 12.62 Million HKD | -34.62% |
| 1999 | 19.31 Million HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 7.26 Million HKD | 85.14% |
| 2023 Q2 | 5.56 Million HKD | 0.0% |
| 2023 Q4 | 7.26 Million HKD | 0.0% |
| 2022 Q2 | 4.11 Million HKD | 0.0% |
| 2022 FY | 3.92 Million HKD | -68.94% |
| 2022 Q4 | 3.92 Million HKD | 0.0% |
| 2021 Q2 | 6.68 Million HKD | 0.0% |
| 2021 Q4 | 12.63 Million HKD | 0.0% |
| 2021 FY | 12.63 Million HKD | 53.79% |
| 2020 Q4 | 8.21 Million HKD | 0.0% |
| 2020 FY | 8.21 Million HKD | -3.14% |
| 2020 Q2 | 6.82 Million HKD | 0.0% |
| 2019 FY | 8.48 Million HKD | 45.6% |
| 2019 Q2 | 6.12 Million HKD | 0.0% |
| 2019 Q4 | 8.48 Million HKD | 0.0% |
| 2018 Q2 | 4.57 Million HKD | 0.0% |
| 2018 Q4 | 5.82 Million HKD | 0.0% |
| 2018 FY | 5.82 Million HKD | 42.05% |
| 2017 FY | 4.09 Million HKD | -46.1% |
| 2017 Q4 | 4.09 Million HKD | 0.0% |
| 2017 Q2 | 5.24 Million HKD | 0.0% |
| 2016 Q2 | 5.31 Million HKD | 0.0% |
| 2016 FY | 7.6 Million HKD | 28.41% |
| 2016 Q4 | 7.6 Million HKD | 0.0% |
| 2015 Q1 | 12.4 Million HKD | -27.23% |
| 2015 Q4 | 5.92 Million HKD | 0.0% |
| 2015 FY | 5.92 Million HKD | -65.26% |
| 2015 Q2 | 12.4 Million HKD | 0.0% |
| 2014 Q1 | 10.2 Million HKD | 10.66% |
| 2014 FY | 17.05 Million HKD | 84.82% |
| 2014 Q4 | 17.05 Million HKD | 0.0% |
| 2014 Q3 | 17.05 Million HKD | 67.03% |
| 2014 Q2 | 10.2 Million HKD | 0.0% |
| 2013 Q2 | 14.64 Million HKD | 0.0% |
| 2013 Q4 | 9.22 Million HKD | 0.0% |
| 2013 Q3 | 9.22 Million HKD | -37.0% |
| 2013 Q1 | 14.64 Million HKD | 11.36% |
| 2013 FY | 9.22 Million HKD | -29.85% |
| 2012 Q2 | 12.06 Million HKD | 0.0% |
| 2012 Q1 | 12.06 Million HKD | -7.06% |
| 2012 FY | 13.15 Million HKD | 1.31% |
| 2012 Q4 | 13.15 Million HKD | 0.0% |
| 2012 Q3 | 13.15 Million HKD | 9.01% |
| 2011 Q4 | 12.98 Million HKD | 0.0% |
| 2011 FY | 12.98 Million HKD | -14.78% |
| 2011 Q2 | 14.49 Million HKD | 0.0% |
| 2010 FY | 15.23 Million HKD | -34.12% |
| 2010 Q4 | 15.23 Million HKD | 0.0% |
| 2010 Q2 | 18.85 Million HKD | 0.0% |
| 2009 Q4 | 23.12 Million HKD | 0.0% |
| 2009 FY | 23.12 Million HKD | -18.27% |
| 2008 FY | 28.29 Million HKD | 51.78% |
| 2007 FY | 18.63 Million HKD | 49.67% |
| 2006 FY | 12.45 Million HKD | -15.67% |
| 2005 FY | 14.76 Million HKD | -5.89% |
| 2004 FY | 15.69 Million HKD | 56.38% |
| 2003 FY | 10.03 Million HKD | -16.41% |
| 2002 FY | 12 Million HKD | 2.35% |
| 2001 FY | 11.72 Million HKD | -7.11% |
| 2000 FY | 12.62 Million HKD | -34.62% |
| 1999 FY | 19.31 Million HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | 40.436% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 99.477% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 97.642% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 98.317% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 97.563% |
| Essex Bio-Technology Limited | 62.82 Million HKD | 88.436% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | 92.607% |
| PuraPharm Corporation Limited | 175.59 Million HKD | 95.863% |
| SSY Group Limited | 1.08 Billion HKD | 99.331% |
| JBM (Healthcare) Limited | 91.58 Million HKD | 92.067% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 97.714% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.979% |